Phase 3 Caesarean Section Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
The C*STEROID Trial: Corticosteroids before planned caesarean section from 35+0 to 39+6 weeks of pregnancy.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
The University of Auckland2,548 enrolled23 locationsACTRN12620000914965
Terminated
Phase 3
The C*STEROID Feasibility Study: a two-site, randomised placebo controlled trial of corticosteroids before planned caesarean section delivery at 35+0 to 39+6 weeks of pregnancy to determine feasibility for recruitment to the C*STEROID Trial.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
University of Auckland400 enrolled1 locationACTRN12618002028280
Recruiting
Phase 3
Ultrasound-Assisted Neuraxial Anaesthesia for Caesarean Section
Difficult neuraxial anaesthesia for elective Caesarean section
Queensland Health216 enrolled1 locationACTRN12614000076673
Not Yet Recruiting
Phase 3
Efficacy of ultrasound guided Transversus Abdominis Plane (TAP) block following major abdominal surgery: a randomised controlled trial.
healthy women undergo elective caesarean section, no allergy to the analgesic drug ropivacaine and morphine.
Department of Anaesthesia, St Vincent's Hospital104 enrolledACTRN12607000389404